The Mauritanian government has taken a significant step towards enhancing its healthcare sector by adopting two decrees to regulate the advertising of medicines and cosmetic products. According to Health Minister Naha Hamdi Mouknass, these decrees are part of the implementation of the presidential program "My Ambition for the Nation" and aim to strengthen the country's pharmaceutical legislation. The decrees focus on protecting citizens from misleading information and preventing health risks associated with low-quality products.
The first decree regulates the promotion and advertising of medicines, recognizing the sensitive nature of pharmaceutical marketing and its direct influence on patients' behavior and therapeutic choices. The decree requires prior authorization for medical information and advertising activities, strict regulation of medical representatives, and accurate and balanced communication about medicines. This move aims to prevent inappropriate self-medication and overdose by ensuring that advertising is based on valid data from market authorization.
The second decree focuses on cosmetic and body hygiene products, which are used daily by a large population and pose a direct public health risk. The decree sets rules for the manufacture, import, storage, and distribution of these products and establishes a quality control mechanism proportional to the risk level of each product category. This regulatory framework seeks to provide consumers with solid health guarantees and equip economic operators with clear rules.
The decrees are expected to provide authorities with the necessary legal instruments to control the market and ensure product quality. By regulating advertising and product quality, the government aims to offer consumers strong health guarantees and provide economic operators with clear rules. This move is part of the government's efforts to build a robust healthcare system and promote public health.
The adoption of these decrees is also seen as a step towards achieving national pharmaceutical sovereignty and reducing dependence on imports. The government has expressed its commitment to encouraging investment in the pharmaceutical industry, both from national and foreign operators, while adhering to international quality and safety standards. This initiative is expected to boost the local production of medicines and reduce the country's reliance on imported products.
The decrees have been welcomed by stakeholders, who see them as a crucial step towards strengthening the country's healthcare system. The regulations are expected to improve the quality of medicines and cosmetic products available in the market, ultimately benefiting consumers. The government's efforts to regulate the pharmaceutical industry and promote public health are seen as a positive development in the country's healthcare sector.
The implementation of these decrees will be closely monitored, and their impact on the healthcare sector will be assessed. The government has emphasized its commitment to ensuring that the regulations are enforced effectively and that the country's healthcare system is strengthened. The adoption of these decrees marks a significant milestone in Mauritania's efforts to improve its healthcare sector and promote public health.
Key points
- The decrees aim to protect citizens from misleading information and ensure product quality.
- The regulations seek to promote national pharmaceutical sovereignty and reduce dependence on imports.
- The decrees are part of the implementation of the presidential program "My Ambition for the Nation".
Reporting sources
- Le gouvernement adopte deux projets de décrets encadrant la publicité des médicaments et les produits cosmétiques · Le Quotidien de Nouakchott